Dayvigo
NDC Package 62856-455-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dayvigo is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies (14.1)]. Marketed by Eisai Inc., this product is identified by NDC 62856-455 and is authorized under FDA application NDA212028.

Identification & Billing

NDC Package Code
62856-455-10
Package Description
5 CARTON in 1 TRAY / 1 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
62856-455
11-Digit Billing Format
62856045510
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dayvigo
Dosage Form
-
Usage Information
DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies (14.1)].

Regulatory & Marketing

Labeler Name
Eisai Inc.
FDA Application #
NDA212028
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-07-2020
End Marketing Date
02-28-2023
Listing Expiration
02-28-2023
Exclude Flag
D
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62856-455-10 identifies a specific commercial package of 5 carton in 1 tray / 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack of Dayvigo, labeled by Eisai Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eisai Inc. on April 07, 2020. The current certification is valid through February 28, 2023.

How is this Eisai Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62856045510. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62856-455-10
11-Digit CMS (5-4-2)
62856-0455-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.